However, the same association between low expression of COX17 and better overall 5-year patient survival was observed for patients with HPV+ HNSCC (p = 0.00040, FDR = 0.012) (Figure 3H), but not patients with HPV- HNSCC (p = 0.35, FDR = 0.59) (Figure 3I). The gene discussed is COX17; the disease is head and neck squamous cell carcinoma.